|
|
|
|
Direct Cost |
Indirect Cost |
|
1R01AA031890-01 |
Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings |
LOYOLA UNIVERSITY CHICAGO |
NIAAA |
$250,000 |
$135,000 |
$385,000 |
1R01HL171586-01 |
Phosphodiesterase 1 (PDE1) Regulation of Myocardial Calcium and Function |
LOYOLA UNIVERSITY CHICAGO |
NHLBI |
$427,651 |
$164,223 |
$591,874 |
1R01HL172492-01A1 |
Structural and functional basis of myocardial dysregulation in genetic cardiomyopathy |
LOYOLA UNIVERSITY CHICAGO |
NHLBI |
$494,991 |
$155,029 |
$650,020 |
1R03CA289838-01 |
Elucidating molecular mechanisms of cabozantinib resistance in liver cancer |
LOYOLA UNIVERSITY CHICAGO |
NCI |
$50,000 |
$27,000 |
$77,000 |
1R21AA031560-01 |
IL-22-STAT3-Nos2 axis in alcohol-mediated exacerbation of UC pathology |
LOYOLA UNIVERSITY CHICAGO |
NIAAA |
$143,750 |
$69,250 |
$213,000 |
1R21AI180555-01A1 |
Cell therapy for GvHD |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$150,000 |
$81,000 |
$231,000 |
1R21AR084183-01 |
The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocols |
LOYOLA UNIVERSITY CHICAGO |
NIAMS |
$156,939 |
$60,070 |
$217,009 |
2R35GM130355-06 |
Host-associated biofilm formation and dispersal mechanisms |
LOYOLA UNIVERSITY CHICAGO |
NIGMS |
$297,000 |
$135,426 |
$432,426 |
3R01AI159945-04S1 |
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2 |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$74,187 |
$40,061 |
$114,248 |
4R01AI159945-04 |
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2 |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$620,626 |
$119,012 |
$739,638 |
5R00GM141268-04 |
Examining Molecular Regulation of Unconventional Cytoplasmic Protein Secretion |
LOYOLA UNIVERSITY CHICAGO |
NIGMS |
$161,688 |
$87,312 |
$249,000 |
5R01AA021517-08 |
Neuromolecular consequences of adolescent binge drinking |
LOYOLA UNIVERSITY CHICAGO |
NIAAA |
$249,487 |
$126,002 |
$375,489 |
5R01AG081251-02 |
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease |
LOYOLA UNIVERSITY CHICAGO |
NIA |
$523,926 |
$133,230 |
$657,156 |
5R01AG082135-02 |
Sex-specific regulation of microRNAs in Alzheimer Disease |
LOYOLA UNIVERSITY CHICAGO |
NIA |
$439,003 |
$214,364 |
$653,367 |
5R01AI078881-13 |
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$483,698 |
$149,111 |
$632,809 |
5R01AI146917-05 |
Data-Driven Mathematical and Computational Modeling of Hepatitis D Infection and Treatment Response |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$570,514 |
$130,206 |
$700,720 |
5R01AI158666-03 |
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$625,164 |
$70,405 |
$695,569 |
5R01AI162694-04 |
Defining the nuclear import pathways of HIV-1 |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$558,619 |
$169,808 |
$728,427 |
5R01AI163119-04 |
Contribution of CdiA to Pseudomonas aeruginosa pathobiology |
LOYOLA UNIVERSITY CHICAGO |
NIAID |
$250,000 |
$119,059 |
$369,059 |
5R01CA197128-09 |
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis |
LOYOLA UNIVERSITY CHICAGO |
NCI |
$251,309 |
$124,954 |
$376,263 |